Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations.
Di Federico A, Angelicola S, Frascino M, Siracusa I, Bisanti B, Ruzzi F, Semprini MS, De Jonge H, De Giglio A, Sperandi F, Brocchi S, Melotti B, Giunchi F, Gruppioni E, Altimari A, Lollini PL, Ardizzoni A, Palladini A, Gelsomino F. Di Federico A, et al. Among authors: angelicola s. JCO Precis Oncol. 2024 Dec;8:e2400240. doi: 10.1200/PO.24.00240. Epub 2024 Dec 5. JCO Precis Oncol. 2024. PMID: 39637338 Free PMC article.
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?
Ruzzi F, Cappello C, Semprini MS, Scalambra L, Angelicola S, Pittino OM, Landuzzi L, Palladini A, Nanni P, Lollini PL. Ruzzi F, et al. Among authors: angelicola s. Cell Commun Signal. 2024 Oct 11;22(1):489. doi: 10.1186/s12964-024-01876-4. Cell Commun Signal. 2024. PMID: 39394159 Free PMC article. Review.
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.
Ruzzi F, Semprini MS, Scalambra L, Palladini A, Angelicola S, Cappello C, Pittino OM, Nanni P, Lollini PL. Ruzzi F, et al. Among authors: angelicola s. Int J Mol Sci. 2023 Aug 19;24(16):12963. doi: 10.3390/ijms241612963. Int J Mol Sci. 2023. PMID: 37629147 Free PMC article. Review.
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC.
Ruzzi F, Angelicola S, Landuzzi L, Nironi E, Semprini MS, Scalambra L, Altimari A, Gruppioni E, Fiorentino M, Giunchi F, Ferracin M, Astolfi A, Indio V, Ardizzoni A, Gelsomino F, Nanni P, Lollini PL, Palladini A. Ruzzi F, et al. Among authors: angelicola s. Transl Lung Cancer Res. 2022 Nov;11(11):2216-2229. doi: 10.21037/tlcr-22-163. Transl Lung Cancer Res. 2022. PMID: 36519016 Free PMC article.
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine.
Ruzzi F, Palladini A, Clemmensen S, Strøbæk A, Buijs N, Domeyer T, Dorosz J, Soroka V, Grzadziela D, Rasmussen CJ, Nielsen IB, Soegaard M, Semprini MS, Scalambra L, Angelicola S, Landuzzi L, Lollini PL, Thorn M. Ruzzi F, et al. Among authors: angelicola s. Biomedicines. 2022 Oct 20;10(10):2654. doi: 10.3390/biomedicines10102654. Biomedicines. 2022. PMID: 36289916 Free PMC article.
IFN-γ and CD38 in Hyperprogressive Cancer Development.
Angelicola S, Ruzzi F, Landuzzi L, Scalambra L, Gelsomino F, Ardizzoni A, Nanni P, Lollini PL, Palladini A. Angelicola S, et al. Cancers (Basel). 2021 Jan 15;13(2):309. doi: 10.3390/cancers13020309. Cancers (Basel). 2021. PMID: 33467713 Free PMC article. Review.